![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 4, 1883-1886, January 22, 1999
,
From the Dana-Farber Cancer Institute and ¶ Department of
Pathology, Harvard Medical School, Boston, Massachusetts 02115, the
The nuclear p300/CBP proteins function as
coactivators of gene transcription. Here, using cells deficient in p300
or CBP, we show that p300, and not CBP, is essential for ionizing
radiation-induced accumulation of the p53 tumor suppressor and thereby
p53-mediated growth arrest. The results demonstrate that deficiency of
p300 results in increased degradation of p53. Our findings suggest that
p300 contributes to the stabilization and transactivation function of
p53 in the cellular response to DNA damage.
Tsukuba Life Science Center, The Institute of Physical
and Chemical Research Koyadai, Tsukuba Science City 305, Japan, and the
§ Department of Radiation and Cellular Oncology, University
of Chicago, Chicago, Illinois 60637
This article has been cited by other articles:
![]() |
D. P. Stiehl, D. M. Fath, D. Liang, Y. Jiang, and N. Sang Histone Deacetylase Inhibitors Synergize p300 Autoacetylation that Regulates Its Transactivation Activity and Complex Formation Cancer Res., March 1, 2007; 67(5): 2256 - 2264. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wirtenberger, S. Tchatchou, K. Hemminki, J. Schmutzhard, C. Sutter, R. K. Schmutzler, A. Meindl, B. Wappenschmidt, M. Kiechle, N. Arnold, et al. Associations of genetic variants in the estrogen receptor coactivators PPARGC1A, PPARGC1B and EP300 with familial breast cancer Carcinogenesis, November 1, 2006; 27(11): 2201 - 2208. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M. Vega, A. Sevilla, and P. A. Lazo p53 Stabilization and Accumulation Induced by Human Vaccinia-Related Kinase 1 Mol. Cell. Biol., December 1, 2004; 24(23): 10366 - 10380. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dornan, M. Eckert, M. Wallace, H. Shimizu, E. Ramsay, T. R. Hupp, and K. L. Ball Interferon Regulatory Factor 1 Binding to p300 Stimulates DNA-Dependent Acetylation of p53 Mol. Cell. Biol., November 15, 2004; 24(22): 10083 - 10098. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Iyer, S.-F. Chin, H. Ozdag, Y. Daigo, D.-E. Hu, M. Cariati, K. Brindle, S. Aparicio, and C. Caldas p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels PNAS, May 11, 2004; 101(19): 7386 - 7391. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Egan, L. Eckmann, F. R. Greten, S. Chae, Z.-W. Li, G. M. Myhre, S. Robine, M. Karin, and M. F. Kagnoff I{kappa}B-kinase{beta}-dependent NF-{kappa}B activation provides radioprotection to the intestinal epithelium PNAS, February 24, 2004; 101(8): 2452 - 2457. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ionov, S.-I. Matsui, and J. K. Cowell A role for p300/CREB binding protein genes in promoting cancer progression in colon cancer cell lines with microsatellite instability PNAS, February 3, 2004; 101(5): 1273 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jin, S. X. Zeng, M.-S. Dai, X.-J. Yang, and H. Lu MDM2 Inhibits PCAF (p300/CREB-binding Protein-associated Factor)-mediated p53 Acetylation J. Biol. Chem., August 16, 2002; 277(34): 30838 - 30843. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kawai, L. Nie, D. Wiederschain, and Z.-M. Yuan Dual Role of p300 in the Regulation of p53 Stability J. Biol. Chem., November 30, 2001; 276(49): 45928 - 45932. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gegonne, J. D. Weissman, and D. S. Singer TAFII55 binding to TAFII250 inhibits its acetyltransferase activity PNAS, October 5, 2001; (2001) 211444798. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vogt Sionov, S. Coen, Z. Goldberg, M. Berger, B. Bercovich, Y. Ben-Neriah, A. Ciechanover, and Y. Haupt c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination Mol. Cell. Biol., September 1, 2001; 21(17): 5869 - 5878. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Richards New Signaling Pathways for Hormones and Cyclic Adenosine 3',5'-Monophosphate Action in Endocrine Cells Mol. Endocrinol., February 1, 2001; 15(2): 209 - 218. [Abstract] [Full Text] |
||||
![]() |
E. Kobet, X. Zeng, Y. Zhu, D. Keller, and H. Lu MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins PNAS, November 7, 2000; 97(23): 12547 - 12552. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Papoutsopoulou and R. Janknecht Phosphorylation of ETS Transcription Factor ER81 in a Complex with Its Coactivators CREB-Binding Protein and p300 Mol. Cell. Biol., October 1, 2000; 20(19): 7300 - 7310. [Abstract] [Full Text] |
||||
![]() |
R. H. Goodman and S. Smolik CBP/p300 in cell growth, transformation, and development Genes & Dev., July 1, 2000; 14(13): 1553 - 1577. [Full Text] |
||||
![]() |
J. V. Falvo, B. M. N. Brinkman, A. V. Tsytsykova, E. Y. Tsai, T.-P. Yao, A. L. Kung, and A. E. Goldfeld A stimulus-specific role for CREB-binding protein (CBP) in T cell receptor-activated tumor necrosis factor alpha gene expression PNAS, April 11, 2000; 97(8): 3925 - 3929. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liu, J. A. Schwartz, and S. C. Brooks Estrogen Receptor Protects p53 from Deactivation by Human Double Minute-2 Cancer Res., April 1, 2000; 60(7): 1810 - 1814. [Abstract] [Full Text] |
||||
![]() |
X. Zeng, X. Li, A. Miller, Z. Yuan, W. Yuan, R. P. S. Kwok, R. Goodman, and H. Lu The N-Terminal Domain of p73 Interacts with the CH1 Domain of p300/CREB Binding Protein and Mediates Transcriptional Activation and Apoptosis Mol. Cell. Biol., February 15, 2000; 20(4): 1299 - 1310. [Abstract] [Full Text] |
||||
![]() |
Y. Nie, H.-H. Li, C. M. Bula, and X. Liu Stimulation of p53 DNA Binding by c-Abl Requires the p53 C Terminus and Tetramerization Mol. Cell. Biol., February 1, 2000; 20(3): 741 - 748. [Abstract] [Full Text] |
||||
![]() |
K. W. Kohn Molecular Interaction Map of the Mammalian Cell Cycle Control and DNA Repair Systems Mol. Biol. Cell, August 1, 1999; 10(8): 2703 - 2734. [Abstract] [Full Text] |
||||
![]() |
X. Zeng, H. Lee, Q. Zhang, and H. Lu p300 Does Not Require Its Acetylase Activity to Stimulate p73 Function J. Biol. Chem., January 5, 2001; 276(1): 48 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. See, D. Calvo, Y. Shi, H. Kawa, M. P.-S. Luke, Z. Yuan, and Y. Shi Stimulation of p300-mediated Transcription by the Kinase MEKK1 J. Biol. Chem., May 4, 2001; 276(19): 16310 - 16317. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhu, J. Yao, G. Wani, M. A. Wani, and A. A. Wani Mdm2 Mutant Defective in Binding p300 Promotes Ubiquitination but Not Degradation of p53. EVIDENCE FOR THE ROLE OF p300 IN INTEGRATING UBIQUITINATION AND PROTEOLYSIS J. Biol. Chem., August 3, 2001; 276(32): 29695 - 29701. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gegonne, J. D. Weissman, and D. S. Singer TAFII55 binding to TAFII250 inhibits its acetyltransferase activity PNAS, October 23, 2001; 98(22): 12432 - 12437. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |